flufenamic acid has been researched along with Prediabetes in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buu-Hoï, NP | 1 |
1 other study available for flufenamic acid and Prediabetes
| Article | Year |
|---|---|
Experimental studies on the problem of chemotherapy in pre-diabetes. I. Hypoglycaemic effects of aromatic and heterocyclic acids.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Cinnamates; Flufenamic Acid; Gibberellins; | 1966 |